Physician profile
Kelly E Shaffer
NPI 1710060017
$5,538.24
in general payments reported to CMS, 2019-2025
41 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $460 · 2021: $528 · 2022: $812 · 2023: $1,094 · 2024: $908 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,146.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,114.78 | 2019-2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $791.01 | 2021-2025 | Interstim |
| Axonics, INC. | $531.44 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $293.37 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $291.40 | 2023-2025 | Desara |
| Medtronic USA, INC. | $242.19 | 2019-2020 | |
| Angiodynamics, INC. | $210.41 | 2023 | Nanoknife |
| Boston Scientific Corporation | $203.58 | 2020-2025 | Axonics |
| Merck Sharp & Dohme LLC | $144.63 | 2021-2025 | Keytruda, Zerbaxa |
| Abbvie INC. | $138.62 | 2024-2025 | |
| Abbott Laboratories | $125.53 | 2019-2022 | |
| Janssen Biotech, INC. | $114.75 | 2025 | Carvykti, Rybrevant |
| Urovant Sciences INC | $113.97 | 2021-2022 | |
| Olympus America INC. | $103.59 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $94.13 | 2021-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $92.45 | 2022-2024 | Urolift |
| Dendreon Pharmaceuticals LLC | $82.66 | 2025 | Provenge |
| Antares Pharma, INC. | $81.38 | 2021-2022 | |
| Bioprotect Medical, INC. | $76.56 | 2025 | Bioprotect Balloon Implant System |
| Ferring Pharmaceuticals INC. | $74.62 | 2020-2024 | Adstiladrin |
| Pfizer INC. | $52.64 | 2021-2024 | |
| Procept Biorobotics Corporation | $48.03 | 2023 | Aquabeam Robotic System |
| Laborie Medical Technologies Corp. | $41.94 | 2025 | Eclipse |
| Cycle Pharmaceuticals INC | $41.56 | 2025 | Venxxiva |
| Duchesnay USA Incorporated | $37.20 | 2019 | |
| Blue Earth Diagnostics | $35.22 | 2019 | |
| Rochester Medical Corporation | $32.68 | 2021 | |
| Verity Pharmaceuticals INC. | $31.33 | 2024 | Trelstar |
| Allergan, INC. | $31.11 | 2019-2020 | |
| Tolmar, INC. | $29.20 | 2025 | Jatenzo, Eligard |
| Convatec INC. | $27.17 | 2022 | |
| Coloplast Corp | $27.08 | 2023-2025 | Speedicath |
| Calyxo, INC. | $26.01 | 2025 | Cvac Aspiration System |
| Ambu INC. | $24.70 | 2023 | |
| Therapeuticsmd, INC. | $23.85 | 2019 | |
| Sagent Pharmaceuticals | $21.44 | 2023 | Glydo |
| Urogen Pharma, INC. | $20.63 | 2024 | |
| Endo USA, INC. | $19.22 | 2024 | Xiaflex |
| Avadel Specialty Pharmaceuticals, LLC | $17.77 | 2019 | |
| Profound Medical Corp. | $17.28 | 2025 | Tulsa-Pro |
| Amag Pharmaceuticals, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.